NorthWest Biotherapeutics Inc (NWBO)

[no2koolaid]

Fireman,

According to Boston Consulting Group, less than 25% of all pharma partnerships between big and small companies are considered successful. Interestingly, this number is not much different than the success rate of M&A (despite what some may think). As a result, it is not merely due diligence but effective negotiations that can take many months from start to finish. I expect that NWBO began the process with a discussion predicted on "when" and now that the "when" has arrived they are finishing up the "how" and that includes payment, milestones, parameters, and all other contractual obligations.

Amidst all the noise about what the ASM will or will not reveal, the timing suggests more rather than less information will be shared. But it will always stop short of the biggest revelations that some expect and, when not forthcoming, argue it was no big deal. As is said, the devil is in the details.